Scholarlink

Objective <p>The World Health Organization identifies colorectal cancer as the third-most diagnosed malignancy and second leading cause of cancer-related mortality worldwide. Up to 30% of patients relapse within 5 years postoperatively; however, conventional staging methods cannot reliably stratify individual risks, underscoring the need for precise, patient-centred decision-support tools.</p> Methods <p>We retrospectively analysed data on 1,789 colorectal cancer patients undergoing curative resection (2013–2023) from the Tri-Service General Hospital registry. Four tree-based machine learning algorithms were trained on demographic, tumour, immunohistochemical, and laboratory features. Patients were divided chronologically into training (January to September) and validation (October to December) sets. Feature importance was assessed using random forest impurity scores and Shapley additive explanations (SHAP). A web-based artificial intelligence-clinical decision support system (AI-CDSS) was developed to provide real-time, scenario-specific five-year recurrence-risk estimates.</p> Results <p>Of the 1,789 patients, 406 (22.7%) experienced recurrence. The top 10 predictors accounted for approximately 43% of the total model importance. SHAP analysis confirmed that tumour burden, biological markers, treatment intensity, and host factors were key drivers of recurrence risk. On the validation set, all models achieved area under the receiver operating characteristic curve values of 0.83–0.84. The random forest-based system demonstrated 87% accuracy, 85% positive predictive value, 87% negative predictive value, and an F1 score of 0.64, and was consequently selected as the AI-CDSS engine.</p> Conclusion <p>The proposed AI-CDSS delivers personalised five-year recurrence-risk estimates for patients with colorectal cancer within 1&#xa0;s via an intuitive web interface, facilitating evidence-based, patient-centred treatment decisions grounded in local population data.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Web-based explainable machine-learning tool for predicting five-year recurrence of colorectal cancer after curative resection: multicentre retrospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月4日

查看全文
  • Chi-Sheng Chen,
  • Tai-Han Lin,
  • Hsing-Yi Chung,
  • Ming-Jr Jian,
  • Chih-Kai Chang,
  • Cherng-Lih Perng,
  • Ping-Ying Chang,
  • Wen-Yen Huang,
  • Chao-Yang Chen,
  • Yu-Chun Lin,
  • Hung-Sheng Shang

摘要

Objective

The World Health Organization identifies colorectal cancer as the third-most diagnosed malignancy and second leading cause of cancer-related mortality worldwide. Up to 30% of patients relapse within 5 years postoperatively; however, conventional staging methods cannot reliably stratify individual risks, underscoring the need for precise, patient-centred decision-support tools.

Methods

We retrospectively analysed data on 1,789 colorectal cancer patients undergoing curative resection (2013–2023) from the Tri-Service General Hospital registry. Four tree-based machine learning algorithms were trained on demographic, tumour, immunohistochemical, and laboratory features. Patients were divided chronologically into training (January to September) and validation (October to December) sets. Feature importance was assessed using random forest impurity scores and Shapley additive explanations (SHAP). A web-based artificial intelligence-clinical decision support system (AI-CDSS) was developed to provide real-time, scenario-specific five-year recurrence-risk estimates.

Results

Of the 1,789 patients, 406 (22.7%) experienced recurrence. The top 10 predictors accounted for approximately 43% of the total model importance. SHAP analysis confirmed that tumour burden, biological markers, treatment intensity, and host factors were key drivers of recurrence risk. On the validation set, all models achieved area under the receiver operating characteristic curve values of 0.83–0.84. The random forest-based system demonstrated 87% accuracy, 85% positive predictive value, 87% negative predictive value, and an F1 score of 0.64, and was consequently selected as the AI-CDSS engine.

Conclusion

The proposed AI-CDSS delivers personalised five-year recurrence-risk estimates for patients with colorectal cancer within 1 s via an intuitive web interface, facilitating evidence-based, patient-centred treatment decisions grounded in local population data.